BLC
MEDP icon

Brown, Lisle/Cummings’s Medpace MEDP Stock Holding History

Brown, Lisle/Cummings’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.06K Buy
+2
New +$923 ﹤0.01% 947

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Brown, Lisle/Cummings's MEDP Position: Q2 2026 in Review

Brown, Lisle/Cummings opened a new position in Medpace (MEDP) in Q2 2026: 2 shares worth $1.06K. The stake represents ﹤0.01% of the portfolio and ranks #947 among its holdings.

697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Brown, Lisle/Cummings held 2 shares of Medpace worth $1.06K as of Q2 2026.
  • Medpace was a new Brown, Lisle/Cummings position in Q2 2026.
  • Medpace made up ﹤0.01% of Brown, Lisle/Cummings's portfolio in Q2 2026, its #947 holding.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Brown, Lisle/Cummings's 13F filing for Q2 2026, filed 2 Sep 2026.